ChinaBio News

ChinaBio will appear in the Feb. issue of Nature Biotechnology.

Click Here to Download

Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News

ChinaBio will appear in the Feb. issue of Nature Biotechnology.

Click Here to Download

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Tianyin Receives SFDA Approval for TCM Asthma Product

publication date: Sep 11, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Tianyin Pharmaceutical, Co. will add to its list of modernized traditional Chinese medicines the recently SFDA-approved Laonian Kechuan Tablets, a new drug for the company which was approved with a dose of 0.25 gram/tablet. The product is aimed at asthma sufferers who are 60 years old and above. Tianyin will begin recording revenue from the product in November 2008. More details...

Stock Symbol: (OTCBB: TYNP)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events

SEED Finalists Coaching Day
March 2, 2010
Shanghai, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
 
Partner Events

March 8–10, 2010
Barcelona, Spain

World CRO Summit 2010
March 11-12, 2010
Shanghai, China

BIO-Europe 2010
Munich, Germany
November 15–17, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners